← Back to headlines
AC Immune Stock Rises After Amending Licensing Deal with Lilly
AC Immune's stock experienced a rise after the company announced an amendment to its licensing deal with pharmaceutical giant Eli Lilly.
7 Apr, 14:45 — 7 Apr, 14:45
Sources
Showing 1 of 1 sources
Related Stories
Global Oil Prices Remain High Amid Persistent Middle East Tensions
just now
Two Suspects Charged in Quezon City Diesel Pilferage Incident
just now
Philippines to Begin Service Contracting for Public Utility Vehicles
just now
Philippine Anti-Money Laundering Council Investigates P802M Flow into Zaldy Co's Accounts
just now